Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 ...

Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines Agency (EMA) for ...

EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announced the appointment of the Company’s Nomination Committee.  According to the instructions for the ...

SciSparc (SPRC)announced that MitoCareX Bio, its joint venture with Dr. Alon Silberman, is expanding its research and ...

EDAP TMS (EDAP) announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Leon Berard, Lyon, France, ...

A (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, ...

Results Demonstrate HIP-Engineered Primary Pancreatic Islet Cells Avoid Immune Detection, Function, and Persist after Intramuscular Transplantation in First Treated Patient with Type 1 Diabetes ...

Hyderabad:Leading oncologists have highlighted the role that alcohol consumption plays in increasing the risk of various ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...

In a compelling episode of "," Dr. John Marshall engages in a profound dialogue with Julie Fleshman, a vanguard in the realm ...